112 related articles for article (PubMed ID: 3816915)
21. Comparison of in vitro glioma cell cytotoxicity of LAK cells from glioma patients and healthy subjects.
Bosnes V; Hirschberg H
J Neurosurg; 1988 Aug; 69(2):234-8. PubMed ID: 3260622
[TBL] [Abstract][Full Text] [Related]
22. [Sensitivity of human glial tumor cells of different grade of anaplasia to lysis due to natural killers depending on some characteristics of the glycoprotein structure of tumor cell membranes].
Lisianyĭ KI; Markova OV; Romodanov SA
Biull Eksp Biol Med; 1991 Aug; 112(8):190-1. PubMed ID: 1786388
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in gliomas.
Korkolopoulou P; Christodoulou P; Lekka-Katsouli I; Kouzelis K; Papanikolaou A; Panayotides I; Mariatos P; Thomas-Tsagli E; Crocker J
Histopathology; 1994 Oct; 25(4):349-55. PubMed ID: 7835840
[TBL] [Abstract][Full Text] [Related]
24. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
[TBL] [Abstract][Full Text] [Related]
26. [Effects of interferons on syngeneic murine malignant glioma-specific killer T cell].
Yamasaki T; Yamashita J; Handa H; Namda Y; Hanaoka M
No Shinkei Geka; 1983 Oct; 11(10):1059-67. PubMed ID: 6196674
[TBL] [Abstract][Full Text] [Related]
27. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
28. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?
Muragaki Y; Chernov M; Maruyama T; Ochiai T; Taira T; Kubo O; Nakamura R; Iseki H; Hori T; Takakura K
Minim Invasive Neurosurg; 2008 Oct; 51(5):275-9. PubMed ID: 18855292
[TBL] [Abstract][Full Text] [Related]
29. "Angioglioma" and the arteriovenous malformation-glioma association.
Lombardi D; Scheithauer BW; Piepgras D; Meyer FB; Forbes GS
J Neurosurg; 1991 Oct; 75(4):589-66. PubMed ID: 1885977
[TBL] [Abstract][Full Text] [Related]
30. Neuropathology of malignant gliomas.
Bruner JM
Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
[TBL] [Abstract][Full Text] [Related]
31. Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies.
Braun DP; Penn RD; Harris JE
Neurosurgery; 1984 Jul; 15(1):29-33. PubMed ID: 6089029
[TBL] [Abstract][Full Text] [Related]
32. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
33. [Quantitative histological observations in gliomas (author's transl)].
Martin H; Schmidt D; Heim I; Scholze K; Tanner G
Zentralbl Allg Pathol; 1980; 124(1-2):31-9. PubMed ID: 6251667
[TBL] [Abstract][Full Text] [Related]
34. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.
Shinozaki N; Uchino Y; Yoshikawa K; Matsutani T; Hasegawa A; Saeki N; Iwadate Y
J Neurosurg; 2011 Jun; 114(6):1640-7. PubMed ID: 21214332
[TBL] [Abstract][Full Text] [Related]
35. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
[TBL] [Abstract][Full Text] [Related]
36. Single agent therapy of interferon for brain tumours: correlation between natural killer activity and clinical course.
Otsuka S; Handa H; Yamashita J; Suda K; Takeuchi J
Acta Neurochir (Wien); 1984; 73(1-2):13-23. PubMed ID: 6208758
[TBL] [Abstract][Full Text] [Related]
37. Isolation and in vitro growth of glioma-infiltrating lymphocytes, and an analysis of their surface phenotypes.
Sawamura Y; Abe H; Aida T; Hosokawa M; Kobayashi H
J Neurosurg; 1988 Nov; 69(5):745-50. PubMed ID: 3054014
[TBL] [Abstract][Full Text] [Related]
38. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
Lauro GM; Grossi M; Di Lorenzo N
Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
[TBL] [Abstract][Full Text] [Related]
39. Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines.
Ciaglia E; Laezza C; Abate M; Pisanti S; Ranieri R; D'alessandro A; Picardi P; Gazzerro P; Bifulco M
Int J Cancer; 2018 Jan; 142(1):176-190. PubMed ID: 28884474
[TBL] [Abstract][Full Text] [Related]
40. Glia-specific antigen in the intracranial tumors. Immunofluorescence study.
Lach B; Weinrauder H
Acta Neuropathol; 1978 Jan; 41(1):9-15. PubMed ID: 345726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
